A Comparative Study of the Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Normal Saline for the Treatment of Dystrophic and Idiopathic Calcinosis Cutis



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:10/12/2018
Start Date:October 30, 2018
End Date:August 17, 2019
Contact:David Weinstein, MD
Email:david.weinstein@ucf.edu
Phone:407-266-4900

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Comparative Study of the Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Normal Saline for the Treatment of Dystrophic and Idiopathic Calcinosis Cutis, A Double-Blind Randomized Placebo-Controlled Trial

The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate
(STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the
treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and
idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.

Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to
the injections of sodium thiosulfate in our patients.

Inclusion Criteria:

- Male or female adult 18 years of age or older

- Must have health insurance will be eligible to participate

- Must have a current diagnosis of dystrophic or idiopathic calcinosis cutis

- Subjects must have at least 2 lesions of at least 2mm in size

Exclusion Criteria:

- Unable to read and speak English

- Allergy to any component of the sodium thiosulfate solution

- Adults unable to consent

- Individuals who are not yet adults (infants, children, teenagers)

- Pregnant women

- Women who are breastfeeding

- Prisoners
We found this trial at
1
site
UCF Health Lake Nona Office
9975 Tavistock Lakes Boulevard
Orlando, Florida 32827
Principal Investigator: David Weinstein, MD
Phone: 407-266-4900
?
mi
from
Orlando, FL
Click here to add this to my saved trials